Recombinant Human Anti-SFTSV Antibody (MAb4-5)
This product is a human monoclonal IgG1 kappan antibody targeting the Gnl domain of glycoprotein N (Gn) of severe fever with thrombocytopenia syndrome virus (SFTSV). This antibody shows the ability to neutralize SFTSV broadly, using the antibody neutralization of the SFTSV, which makes the antibody a specific drug and so clinically useful in preventing SFTSV through the treatment studies of diseases caused by infection.
Recombinant Human Anti-SFTSV Antibody (MAb4-5)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
This product is a human monoclonal IgG1 kappan antibody targeting Gnl domain of glycoprotein N (Gn) of severe fever with thrombocytopenia syndrome virus (SFTSV). This antibody shows the ability to SFTSV broad spectrum, using the antibody neutralization of the SFTSV, which made antibody specific drugs, and so as to be clinically useful in the prevention SFTSV by the treatment studies of diseases caused by infection, it has a strong clinical and economic value. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Recombinant Human Anti-SFTSV Antibody (MAb4-5)
- abbr: Recombinant Anti-SFTSV Antibody (MAb4-5)
- Target: SFTSV
- Host Animal: Human
- Specificity: SFTSV Gnl domain of glycoprotein N
- Immunogen: Purified SFTSV virus
Relevant Applications
- Neut
- ELISA
- WB
- SPR
- IF
- EM
- The SFTSV antibody has been reported in applications of Neutralization
- Enzyme-linked Immunosorbent Assay
